| 1 |
35183859 | Discovery of EGFR-Targeted Environment-Sensitive fluorescent probes for cell imaging and efficient tumor detection. | 2022 Apr |
2 |
| 2 |
33269993 | Comprehensive identification, fragmentation pattern, and metabolic pathways of gefitinib metabolites via UHPLC-Q-TOF-MS/MS: in vivo study of rat plasma, urine, bile, and faeces. | 2021 Mar |
3 |
| 3 |
33849825 | [Establishment of animal models of epidermal growth factor receptor inhibitor-related rashes]. | 2021 Mar 25 |
1 |
| 4 |
34830377 | Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands. | 2021 Nov 19 |
3 |
| 5 |
31264901 | Augmented Pulmonary Vasoconstrictor Reactivity after Chronic Hypoxia Requires Src Kinase and Epidermal Growth Factor Receptor Signaling. | 2020 Jan |
2 |
| 6 |
32111605 | EGFR Signaling Causes Morphine Tolerance and Mechanical Sensitization in Rats. | 2020 Mar/Apr |
3 |
| 7 |
32370496 | EGFR Inhibitor Gefitinib Induces Cardiotoxicity through the Modulation of Cardiac PTEN/Akt/FoxO3a Pathway and Reactive Metabolites Formation: In Vivo and in Vitro Rat Studies. | 2020 Jul 20 |
5 |
| 8 |
33025329 | Gefitinib-Induced Cutaneous Toxicities in Brown Norway Rats Are Associated with Macrophage Infiltration. | 2020 Dec |
4 |
| 9 |
29228391 | Arsenic Attenuates Heparin-Binding EGF-Like Growth Factor/EGFR Signaling That Promotes Matrix Metalloprotease 9-Dependent Astrocyte Damage in the Developing Rat Brain. | 2018 Apr 1 |
3 |
| 10 |
29396379 | Therapeutic effects of gefitinib-encapsulated thermosensitive injectable hydrogel in intervertebral disc degeneration. | 2018 Apr |
3 |
| 11 |
26677863 | Inhibition of EGF Receptor Blocks the Development and Progression of Peritoneal Fibrosis. | 2016 Sep |
2 |
| 12 |
27669229 | The Epidermal Growth Factor Receptor (EGFR) Inhibitor Gefitinib Reduces but Does Not Prevent Tumorigenesis in Chemical and Hormonal Induced Hepatocarcinogenesis Rat Models. | 2016 Sep 23 |
4 |
| 13 |
25788532 | EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy. | 2015 Nov |
1 |
| 14 |
23559083 | Thyroid cancer cell resistance to gefitinib depends on the constitutive oncogenic activation of the ERK pathway. | 2013 Jun |
4 |
| 15 |
23632456 | ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions. | 2013 Apr 30 |
1 |
| 16 |
21982874 | Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer. | 2012 Feb |
2 |
| 17 |
22450006 | Epidermal growth factor receptor-tyrosine kinase inhibitor (gefitinib) augments pneumonitis, but attenuates lung fibrosis in response to radiation injury in rats. | 2012 |
4 |
| 18 |
22967907 | Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells. | 2012 Sep 11 |
2 |
| 19 |
21369704 | Efficacy of the EGFr inhibitor Iressa on development of chemically-induced urinary bladder cancers: dose dependency and modulation of biomarkers. | 2011 May |
1 |
| 20 |
21887704 | The critical role of the epidermal growth factor receptor in endochondral ossification. | 2011 Nov |
1 |
| 21 |
21925118 | Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells. | 2011 Oct |
2 |
| 22 |
19850946 | Role of epidermal growth factor inhibition in experimental pulmonary hypertension. | 2010 Jan 15 |
1 |
| 23 |
20962455 | Antipsychotic potential of quinazoline ErbB1 inhibitors in a schizophrenia model established with neonatal hippocampal lesioning. | 2010 |
1 |
| 24 |
18180313 | Testosterone-stimulated growth of the rat prostate may be driven by tissue hypoxia and hypoxia-inducible factor-1alpha. | 2008 Jan |
2 |
| 25 |
18375820 | Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes. | 2008 Apr |
2 |
| 26 |
18413814 | Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model. | 2008 Apr 15 |
2 |
| 27 |
18519677 | RET/PTC-induced cell growth is mediated in part by epidermal growth factor receptor (EGFR) activation: evidence for molecular and functional interactions between RET and EGFR. | 2008 Jun 1 |
1 |
| 28 |
18630690 | [Effect of gefinitib on airway mucus hypersecretion induced by acrolein in rats]. | 2008 Mar |
4 |
| 29 |
16488438 | Epidermal growth factor receptor and hedgehog signaling pathways are active in esophageal cancer cells from rat reflux model. | 2006 Jul |
3 |
| 30 |
16988945 | Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib. | 2006 Dec 1 |
1 |
| 31 |
17003482 | Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib. | 2006 Oct |
2 |
| 32 |
17043666 | Inhibition of EGFR signaling abrogates smooth muscle proliferation resulting from sustained distension of the urinary bladder. | 2006 Dec |
1 |
| 33 |
15660382 | Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. | 2005 Feb |
4 |
| 34 |
15033924 | Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition. | 2004 May |
1 |
| 35 |
12219038 | A serum factor after intestinal resection stimulates epidermal growth factor receptor signaling and proliferation in intestinal epithelial cells. | 2002 Aug |
1 |
| 36 |
11479217 | Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors. | 2001 Aug 1 |
2 |